These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6120715)

  • 1. Haemodynamic effects of cigarette smoking during beta-adrenoceptor blockade.
    Freestone S; Ramsay LE
    Br J Clin Pharmacol; 1982 Feb; 13(2):258-60. PubMed ID: 6120715
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic effects of cigarette smoking before and during long-term non-selective and selective beta-adrenergic blockade in patients with arterial hypertension.
    Tangø M; Krogsgaard AR; Trap-Jensen J; Schläger J
    Acta Med Scand Suppl; 1985; 693():111-4. PubMed ID: 2859738
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic effects of cigarette smoking during chronic selective and non-selective beta-adrenoceptor blockade in patients with hypertension.
    Houben H; Thien T; Van 'T Laar A
    Br J Clin Pharmacol; 1981 Jul; 12(1):67-72. PubMed ID: 6113840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the haemodynamic effects of alpha- and beta-blockade in essential hypertension.
    Taylor SH
    Br J Clin Pract Suppl; 1987 Dec; 54():22-31. PubMed ID: 2905159
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral haemodynamic effects of beta-adrenoceptor blocking drugs with ISA or relative beta 1-selectivity at rest and during physical exercise.
    Rieckert H; Kattwinkel W; Riechelmann H; Kuss A; Sierau R
    Br J Clin Pharmacol; 1982; 13(Suppl 2):227S-228S. PubMed ID: 6125173
    [No Abstract]   [Full Text] [Related]  

  • 6. How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.
    Man in 't Veld AJ; Schalekamp MA
    Br J Clin Pharmacol; 1982; 13(Suppl 2):245S-257S. PubMed ID: 6125175
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.
    van Zwieten PA
    Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smoking and beta adrenergic receptor blockade].
    Carlsen JE; Svendsen TL; Christensen NJ; Trap-Jensen J
    Ugeskr Laeger; 1980 Feb; 142(8):504-8. PubMed ID: 6102813
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
    Daul A; Johnston T; Reher M; Krüger M; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Performance modification in sports by beta receptor blockers].
    Aigner A
    Wien Med Wochenschr; 1990 Apr; 140(6-7):163-70. PubMed ID: 1971979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents--effects on hemodynamics].
    Miyazaki M; Mitsufuji T; Yokono S
    Masui; 1985 Mar; 34(3):272-9. PubMed ID: 2862296
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction of cigarette smoking and beta-adrenoceptor blockade.
    Fox K; Deanfield J; Krikler S; Ribeiro P; Wright C
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):92S-93S. PubMed ID: 6146345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease.
    Krag A; Wiest R; Albillos A; Gluud LL
    Gut; 2012 Jul; 61(7):967-9. PubMed ID: 22234982
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-adrenoceptor blockade and intrinsic sympathomimetic activity--relevance in the treatment of ischaemic heart disease.
    Northcote RJ; Ballantyne D
    Scott Med J; 1985 Oct; 30(4):208-15. PubMed ID: 2869581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.
    Richards DA; Prichard BN; Dobbs RJ
    Clin Pharmacol Ther; 1978 Sep; 24(3):264-73. PubMed ID: 28869
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-adrenoceptor and of combined sympathetic and parasympathetic blockade on cardiac performance and vascular resistance.
    Kelbaek H; Frandsen H; Hilsted J; Christensen NJ; Nielsen SL
    Br J Clin Pharmacol; 1992 May; 33(5):473-6. PubMed ID: 1355981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings].
    Bianchetti G; Cadigan PJ; Gomeni R; Kilborn JR; London DR; Morselli PL; Pentecost BL
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P. PubMed ID: 41555
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacodynamic profile of carvedilol.
    van Zwieten PA
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.